Challenges to implementation of artemisinin combination therapy policy in Uganda

WHO. Antimalarial drug combination therapy. Report of a technical consultation. Geneva: World Health Organization; 2001. WHO. Access to antimalarial medicines: improving the affordability and financing of artemisinin based combination therapies. Geneva: World Health Organization; 2003. Checchi, 2004, Antimalarial efficacy of sulphadoxine-pyrimethamine, Amodiaquine and a combination of chloroquine plus sulphadoxine-pyrimethamine in Bundi Bugyo, western Uganda, Trop Med Int Health, 9, 445, 10.1111/j.1365-3156.2004.01217.x Malaria Control Programme. National Policy on Malaria Treatment 2005. Kampala, Uganda: Ministry of Health; 2005. Malaria Control Programme. Antimalarial Drug Policy Chart. 2nd ed. Kampala, Uganda: Ministry of Health; 2005. Kamya, 2002, Increasing antimalarial drug resistance in Uganda and revision of the national drug policy, Trop Med Int Health, 7, 1031, 10.1046/j.1365-3156.2002.00974.x Williams, 2004, The process of changing national malaria treatment policy: lessons from country level studies, Health Policy Plan, 19, 356, 10.1093/heapol/czh051 Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale W, et al. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J 2007;6:72, doi:10.1186/1475-2875-6-72. Zurovac, 2004, Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya, Int J Epidemiol, 33, 1080, 10.1093/ije/dyh253 Nicholas, 1991, The Quality Assurance Project: introducing quality improvement to primary health care in less developed countries, Qual Assur Health Care, 3, 147, 10.1093/intqhc/3.3.147 Ofori-Adjei, 1996, Effects of training on the clinical management of malaria by medical assistance in Ghana, Soc Sci Med, 42, 1169, 10.1016/0277-9536(95)00389-4 Uganda Bureau of Statistics. Uganda population and housing census analytical report: Bushenyi District Local Government Planning Unit. Bushenyi, Uganda 2007. Uganda Bureau of Statistics. Uganda population and housing census analytical report: Iganga District Local Government Planning Unit. Iganga, Uganda 2007. Malaria Control Programme. Management of uncomplicated malaria: a practical guide for health workers. Kampala, Uganda: Ministry of Health; 2005. Malaria Control Programme. Flowchart for management of malaria. Kampala, Uganda: Ministry of Health; 2005. Kish, 1965 The PLoS Medicine Editors. Time for a “Third Wave” of Malaria Activism to Tackle the Drug Stock-out Crisis. PLoS Med 2009; 6: e1000188. doi:10.1371/journal.pmed.1000188. Nabyonga, 2005, Abolition of cost-sharing is pro-poor: evidence from Uganda, Health Policy Plan, 20, 100, 10.1093/heapol/czi012 Talisuna AO. The process of malaria drug policy change in Uganda: practical realities in implementing new treatment policies. Presented at: Expanding reach of ACTs in the private sector: dialogue with countries. MMV Access Symposium 2008 Accra, Ghana. Kangwana, 2009, Malaria drug shortages in Kenya: a major failure to provide access to effective treatment, Am J Trop Med Hyg, 80, 737, 10.4269/ajtmh.2009.80.737 Zurovac, 2007, Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study, Malar J, 16, 31, 10.1186/1475-2875-6-31 Nuwaha, 2002, People's perception of malaria in Mbarara, Uganda. Trop Med Int Health, 7, 462, 10.1046/j.1365-3156.2002.00877.x Amuge, 2004, Health-seeking behaviour for malaria among child and adult headed households in Rakai district, Uganda, Afr Health Sci, 4, 119 Martin Enserink. GLOBAL HEALTH: Malaria Drugs, the Coca-Cola Way. Science 2008; 322:1174. DOI:10.1126/science.322.5905.1174. Zurovac, 2008, Malaria case-management under artemether-lumefantrine treatment policy in Uganda, Malar J, 19, 181, 10.1186/1475-2875-7-181 Wasunna B, Zurovac D, Goodman CA, Snow RW. Why don’t health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J 2008;7:29, doi:10.1186/1475-2875-7-29. Nuwaha, 2001, The challenge of chloroquine-resistant malaria in sub-Saharan Africa, Health Policy Plan., 16, 1, 10.1093/heapol/16.1.1 D’Acremont, 2009, Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever, PLoS Med, 6, e252, 10.1371/journal.pmed.0050252 WHO. Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010. http://www.who.int/malaria/publications/atoz/9789241547925/en/. [accessed 5 April 2010]. Guthmann, 2002, Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda, Trans R Soc Trop Med Hyg., 96, 254, 10.1016/S0035-9203(02)90091-X